Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

NLG919

Product Specifications

Background

NLG919 (1402836-58-1) is a potent IDO-pathway inhibitor (Ki = 7nM; EC50 = 75nM) .1 It synergizes with chemo-radiation therapy to promote T cell dependent complement deposition in a murine model of glioblastoma.2 In combination with paclitaxel in a mouse B16-F10 melanoma model, NLG919 increased the percentage of CD3+, CD8+, and CD4+ T cells and secretion of IFN-γ and interleukin-2 while decreasing the percentage of CD4+CD25+ regulatory T cells.3

Conjugation

Unconjugated

Buffer

White solid

Storage Conditions

-20°C

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Recombinant Human SulT1B1 Protein, His Tag
KMH1766-01 100 µg

Recombinant Human SulT1B1 Protein, His Tag

Sign In for Pricing
View Details
Recombinant Human SulT1B1 Protein, His Tag
KMH1766-02 50 µg

Recombinant Human SulT1B1 Protein, His Tag

Sign In for Pricing
View Details
Canine Interleukin 2 (IL2) ELISA Kit
EK14880 48 Tests

Canine Interleukin 2 (IL2) ELISA Kit

Sign In for Pricing
View Details
RNASEH2C Polyclonal Conjugated Antibody
MBS9439994-01 0.1 mL (Biotin)

RNASEH2C Polyclonal Conjugated Antibody

Sign In for Pricing
View Details
RNASEH2C Polyclonal Conjugated Antibody
MBS9439994-02 0.1 mL (AF350)

RNASEH2C Polyclonal Conjugated Antibody

Sign In for Pricing
View Details
RNASEH2C Polyclonal Conjugated Antibody
MBS9439994-03 0.1 mL (AF405)

RNASEH2C Polyclonal Conjugated Antibody

Sign In for Pricing
View Details